Argo Biopharma

Argo Biopharma is a clinical-stage biotechnology company committed to developing next-generation siRNA therapies to provide better treatment options for patients worldwide. We have a robust and diverse pipeline of RNAi drug candidates targeting a broad range of indications and are advancing six therapeutic candidates in the clinic. We leverage the power of collaboration to bolster our innovation engine to deliver best-in-class siRNA therapeutics while building top-tier clinical capabilities across multiple geographies.